// App-Quantinova.ai

: Do atrial fibrillation detection rates differ based on presenting symptomatology in patients at risk of atrial fibrillation and stroke? Results from the REVEAL AF study

Researchers

Presenter

  • J.A. Reiffel

Principal Investigators

  • A. Verma

  • P.R. Kowey

  • J.L. Halperin

  • B.J. Gersh

  • P.D. Ziegler

  • E. Pouliot

  • R. Wachter

Medical Centers

  • Columbia University, Division of Cardiology, Department of Medicine, New York, United States of America

  • Southlake Regional Health Centre, Department of Cardiology, Newmarket, Canada

  • Lankenau Institute for Medical Research, Department of Internal Medicine-Cardiology, Wynnewood, United States of America

  • Mount Sinai Medical Center, Cardiovascular Institute, Department of Medicine-Cardiology, New York, United States of America

  • Mayo Clinic, Division of Cardiovascular Diseases, Rochester, United States of America

  • Medtronic, Inc., Medtronic Patient Monitoring & Diagnostics, Mounds View, United States of America

  • University of Göttingen; German Cardiovascular Research Center (DZHK), Department of Cardiology and Pneumology, Göttingen, Germany

Locations

  • Canada

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Medtronic

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved